Table 1.
Name | Forward (5’–3’) | Reverse (5’–3’) |
---|---|---|
MyoG | CAAATCCACTCCCTGAAA | GCATAGGAAGAGATGAACA |
MYH1 | GGGAAACTGGCTTCTGCTGAT | TGGGTTGGTGGTGATTAGGAG |
MYH2 | GTCAAAGGGACTATCCAGAGCAG | AGAAGAGGCCCGAGTAGGTGT |
MYH4 | CTCCTAATCACCACCAACCCATA | TGTCAGCAACTTCAGTGCCATC |
MYH7 | AAGACAGTGACCGTGAAGGAGG | GGTTGATGGTGACGCAGAAGA |
ACVR1B | TGCCCTCTGACCCTTCCATC | CACTCCCGCATCATCTTCCC |
bta-miR-24-3p | CAGTGGCTCAGTTCAGCAGGA | |
18s | GTAACCCGTTGAACCCCATT | CCATCCAATCGGTAGTAGCG |
Cyclin D1 | GACGAGCTGCTGCACATGGA | TGCTTGTTCTCCTCGGCCAC |
Cyclin B1 | TGGGAGAGACATAAACGG | TGGAAGCCAAGAGCAGTG |
PCNA | GCTGTGTAGTAAAGATGCCT | ATCTCTATGGCAACAGCTTC |
CDK2 | TCTTTGCTGAGATGGTGACCC | TAACTCCTGGCCAAACCACC |
CDKN1A | AAACGGCGGCAGACC | GCCCAAGGCAAAAGG |
MyoG: myogenin; MYH: myosin heavy chain; PCNA: proliferating cell nuclear antigen; CDK2: cyclin-dependent kinase 2; CDKN1A: cyclin-dependent kinase inhibitor 1A.